Vivos Therapeutics (VVOS) Retained Earnings (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Retained Earnings of -$133.0 million for Q1 2026, down 218.3% year-over-year from $112.5 million in Q1 2025, and down 207.41% quarter-over-quarter from $123.9 million in Q4 2025.
Vivos Therapeutics (VVOS) Retained Earnings (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Retained Earnings for 8 consecutive years, with -$133.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 218.3% year-over-year to -$133.0 million; the TTM figure through Mar 2026 stood at -$133.0 million (down 218.3% YoY), while the FY2025 annual figure was $123.9 million, up 10.46% from the prior year.
- Retained Earnings retreated to -$133.0 million in Q1 2026 per VVOS's latest filing, from $123.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $123.9 million in Q4 2025 and bottomed at -$133.0 million in Q1 2026.
- Historically, Retained Earnings has averaged -$11.4 million across 5 years, with a median of -$73.4 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 311.68% — and 2026, when it plunged 218.3%.
- Vivos Therapeutics' Retained Earnings stood at $84.3 million in 2022, then sank by 210.42% to -$93.1 million in 2023, then soared by 220.52% to $112.1 million in 2024, then rose by 10.46% to $123.9 million in 2025, then plunged by 207.41% to -$133.0 million in 2026.
- Business Quant data shows VVOS's Retained Earnings at -$133.0 million in Q1 2026, $123.9 million in Q4 2025, and $121.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -138.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.04 Mn |
| Dec 31, 2025 | 123.87 Mn |
| Sep 30, 2025 | 121.00 Mn |
| Jun 30, 2025 | -113.10 Mn |
| Mar 31, 2025 | 112.46 Mn |
| Dec 31, 2024 | 112.14 Mn |
| Sep 30, 2024 | -101.40 Mn |
| Jun 30, 2024 | 105.09 Mn |
| Mar 31, 2024 | -96.80 Mn |
| Dec 31, 2023 | -93.05 Mn |
| Sep 30, 2023 | -88.80 Mn |
| Jun 30, 2023 | -86.70 Mn |
| Mar 31, 2023 | -81.17 Mn |
| Dec 31, 2022 | 84.27 Mn |
| Sep 30, 2022 | -73.40 Mn |
| Jun 30, 2022 | -67.95 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Dec 31, 2021 | 81.16 Mn |
| Sep 30, 2021 | -48.23 Mn |
| Jun 30, 2021 | -42.78 Mn |